T. Rowe Price Associates
ATEX icon

T. Rowe Price Associates’s Anterix ATEX Stock Holding History

T. Rowe Price Associates’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$304K Buy
+7,955
New +$252K ﹤0.01% 2673

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
PM
Plustick Management Charlottesville, Virginia $207M AUM 253.94% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates's ATEX Position: Q1 2026 in Review

T. Rowe Price Associates opened a new position in Anterix (ATEX) in Q1 2026: 7,955 shares worth $304K. The stake represents ﹤0.01% of the portfolio and ranks #2673 among its holdings.

132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • T. Rowe Price Associates held 7,955 shares of Anterix worth $304K as of Q1 2026.
  • Anterix was a new T. Rowe Price Associates position in Q1 2026.
  • Anterix made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2673 holding.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.